Search

Advanced filters
201 - 249 of 249 items << < 1 2 3 4 5 

EFFICACY OF PANCRAGEN PEPTIDE IN ELDERLY PATIENTS WITH TYPE 2 DIABETES MELLITUS

Korkushko O. V., Shatilo V. B., Havinson W. H., Antonyuk-Shcheglova I. A.
5-10
2010-10-12

ALBUMINURIA AS A MARKER OF ENDOTHELIAL DYSFUNCTION AND EARLY PREDICTOR OF CARDIOVASCULAR COMPLICATION IN PATIENTS WITH DIABETES MELLITUS

Kravchun N. A., Zemlianitsyna O. V., Cherniavskaya I. V., Karachentsev Yu. I.
7-16
2021-08-17

Diagnostic significance of the endopulmonary cytogram in type 1 diabetes mellitus

Pivovarova O. A.
31-38
2013-12-20

THE CLINICAL ASPECTS OF DIABETIC FOOT

Aga¸ci F., Hasho S., Idrizi M., Sadedini A., Tafaj S., Celo E.
14-22
2021-08-18

MECHANISMS OF THE PATHOGENESIS OF ATHEROSCLEROSIS IN PATIENTS WITH DIABETES. THE ROLE OF NF-КВ (тhe literature review)

Sokolova L. K., Pushkarev V. M., Pushkarev V. V., Tronko M. D.
64-76
2021-08-18

AGE PECULIARITIES OF STRUCTURE OF THE TYPE 2 DIBETES MELLITUS RISKFACTOR IN THE CO-WORKERS OF MEDICAL ORGANIZATION OF KHARKIV

Ilyina I. M., Kazakov A. V., Misyura Ye. V., Zubko M. I., Belecka O. M.
38-42
2012-03-15

CONCERNING OF ACHIEVEMENT COMPENSATION OF TYPE 2 DIABETES MELLITUS

Romanova I. P., Chernyavska I. V., Gonharova O. A., Oleinikova S. P., Kholodniy A. V., Gasanova H. A., Kravchun N. A.
22-29
2014-05-22

MORPHOFUNCTIONAL CHANGES OF PL ATELETS IN PATIENTS WITH T YPE II DIABETES MTLLITUS: POSSIBILITY BY α-LIPOIC ACID CORRECTION

Sidoryak N. G., V'unitsky V. P., Rozova K. V.
92-98
2020-11-12

ONE-NUCLEOTIDE POLYMORPHISM OF THE ADIPONEKTIN GENE +45 T> H AND FUNCTIONAL LEVEL OF INSULIN RESISTANCE IN PATIENTS WITH TYPE 2 DIABETES (literature review and own data)

Gorshunska M. Yu.
83-94
2011-09-27

THE PROBLEM OF NEUROENDOCRINE DYSFUNCTIONS IN PATIENTS WITH SCHIZOPHRENIA AND SCHIZOAFFECTIVE DISORDER (literature review)

Pidkorytov V. S., Syerikova O. I., Serikova O. S., Baybarak N. A., Ukrayinskyy S. A., Skrynnik O. V.
100-112
2021-08-17

Exact measurement of glycemia — the main component of self-control of diabetes mellitus

Tykhonova T. M., Smilka Y. N. , Khyzhnyak O.O.
42-48
2021-06-30

CONTEMPORARY IDEAS ABOUT PATHOPHYSIOLOGICAL MECHANISMS OF IMMUNITY DESTRUCTION IN THE PRECLINICAL STAGE OF TYPE 1 DIABETES

Popova V. V., Zak K. P., Tron’ko N. D.
136-143
2019-08-28

CERULOPLASMIN LEVEL AND ITS RELATIONSHIP WITH METABOLIC PARAMETERS IN PATIENTS WITH TYPE 2 DIABETES CONCURRENT WITH NONALCOHOLIC FATTY LIVER DISEASE

Zemlyanitsyna O. V.
22-28
2015-12-03

MODERN NATUROPATHIC APPROACH AND ITS EFFECT ON THE RHEOLOGICAL PROPERTIES OF BILE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS COMORBID WITH METABOLIC SYNDROME

Prystupiuk L. O., Barabanchyk O. V., Slobodyanik M. P.
45-49
2013-03-25

LIPIDEMIC PROFILE AND RENAL FUNCTION IN PATIENTS WITH A COMPENSATION IN TYPE 2 DIABETES MELLITUS IN A CORRECTION OF HYPERTENSION WITH ANTAGONISTS RECEPTOR ANGIOTENSIN II

Pertseva N. O.
35-42
2014-12-08

ANTITHROBOCYTIC THERAPY IN CORRECTION OF COAGULATION DISORDERS IN TYPE 2 DIABETES MELLITUS

Yefimov A. S., Shulyarenko L. V.
11-17
2010-10-12

METFORMIN - THE FIRST STEP IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS

Kravchun N. O.
94-97
2012-03-15

THE EFFECT OF ARTERIAL HYPERTENSION AND GLUCOSE HOMEOSTASIS VIOLATIONS ON CARDIOMYOPATHY SEVERITY IN PATIENTS WITH ACROMEGALY

Mykytyuk M. R.
46-56
2013-10-10

POLYMORPHISM OF THE GENE ENCODING ADIPONEKTIN (+276 G> T ADIPOQ), AND EXPRESSION OF INSULIN-RESISTANT CONDITION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (literature review and own data)

Karachentsev Yu. I., Gorshunska M. Y., Atramentova L. O., Kravchun N. A., Khyzhnyak O. O., Tyzhnenko T. V., Grinchenko T. S., Gladkich A. I., Leshchenko Zh. A., Opaleiko Y. A., Pochernyayev A. K., Romanova I. P., Poltorak V. V.
68-78
2011-06-02

FUNCTIONAL RELEVANCE OF THE INTERLEUKINE-6 GENE POLYMORPHISM RS1800795 IN PATIENTS WITH T YPE 2 DIABETES OF THE EAST UKRAINIAN POPULATION

Krasova N. S., Karachentsev Yu. I., Gorshunska M. Yu., Tyzhnenko T. V., Pochernyaev A. K., Kolesnikova A. O., Leshchenko Z. A., Gladkih A. I., Voropai T. I., Romanova I. P., Jansen E., Kravchun N. O., Poltorak V. V.
71-76
2020-11-12

ROLE OF GLYCOSYL ATED HEMOGLOBIN TESTING IN PATIENTS WITH CEREBRAL STROKE

Flomin Y. V., Gurianov V. G., Sokolova L. K., Taran L. F., Sokolova L. I.
66-74
2021-03-03

EFFECT OF POTENTIAL INHIBITOR OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE OF TYPE 1 ON THE FUNCTIONAL-METABOLIC PARAMETERS IN RATS WITH EXPERIMENTAL TYPE 2 DIABETES MELLITUS

Krasova N. S., Gladkih A. I., Lipson V. V., Leshchenko Z. A., Tyzhnenko T. V., Opaleiko Y. A., Zubatyuk T. O., Svidlo I. M., Yaremenko F. G., Poltorak V. V.
60-66
2014-12-08

EFFICIENCY OF INSULINOTHERAPY OF DIABETES MELLITUS TYPE 1 IN CHILDREN AND ADOLESCENTS

Budreiko O. A.
15-22
2010-06-09

DIABETIC OSTEOARTHROPATHY (SHARCO FOOT)

Sviridov N. V.
79-86
2013-06-18

QUALITY OF LIFE DYNAMICS IN PATIENTS WITH DIABETIC FOOT SYNDROME WITH COMBINED TREATMENT BY PHYSIOTHERAPY AND AUTOLOGOUS PLASMA*

Kharchenko T. O., Melekhovets O. K., Melekhovets Iu. V., Radko A. S., Kalashnyk N. V., R. S. N. Shu
74-80
2020-05-20

CYBERNETIC ONE-COMPARTMENT MODEL OF GLYCEMIA DYNAMICS IN GLUCOSE HOMEOSTASIS DISORDERS

Mykytyuk M. R., Khyzhnyak O. O., Sokol Y. I., Lapta S. S., Soloviova O. I.
58-64
2021-09-14

THE INFLUENCE OF TAURINE-CONTAINING MEDICINE «KRATAL» ON METABOLIC SYNDROME DEVELOPMENT INDUCED BY HIGH FAT DIET

Zvyagina T. S., Gorbenko N. I., Borikov A. Yu., Shalamay A. S.
67-73
2013-06-18

IS THERE ANY POINT INCARDIOMETABOLIC THERAPY IN THE TREATMENT OF PATIENTS WITH CORONARY ARTERY DISEASE AND TYPE 2 DIABETES MELLITUS? (literature review)

Zhuravlyova L. V., Lopina N. A.
105-120
2021-06-24

THE VALUE OF THE TUMOR NECROSIS FACTOR-ALPHA AND VASPIN RATIO IN THE DEVELOPMENT OF INSULIN RESISTANCE

Zhuravlyova L. V., Pylov D. I.
113-120
2019-08-28

VITEFFECT OF NOOTROPIC AND NEUROPROTECTOR PRODUCTS PROPERTIES OF ENERGY METABOLISM PROCESSES AND MANIFESTATIONS OF MITOCHONDRIAL DYSFUNCTION IN THE NEURONS OF THE MAIN BRAIN OF RATS WITH ALOXAN DIAMIN D STATUS IN ADOLSECENTS WITH TYPE 1 DIABETES MELLITUS

Zhylyuk V. I., Mamchur V. Y., Pavlov S. V., Bukhtiyarova N. V.
69-74
2010-10-12

MODERN DIAGNOSTICAL MARKERS OF DIABETICAL NEUROPATHY

Kravchun N. A., Kryvovyaz Yu. O.
104-112
2012-10-10

THE INFLUENCE OF MAGNETIC AND MAGNETIC L ASER THERAPY ON DIABETIC NEUROPATHY IN HYPERTENSION PATIENTS IN THE FAMILY DOCTOR’S PRACTICE

Voloshyna O. B., Chaika A. A., Dukova O. R., Naidyonova O. V.
33-38
2020-11-12

TYPE 1 DIABETES MELLITUS COMPENSATION AND FACTORS OF CHILDREN AND ADOLESCENT DISORDERS (literature review and own data)

Budreyko E. A.
70-77
2012-03-15

DEVELOPMENT OF THE RELATED ANEMIC SYNDROME IN VARIOUS TYPES OF ENDOCRINE PATHOLOGY

Piriatinska N. E., Vdovichenco V. Yu., Bakuridze-Manina V. B., Nekhanevych O. B., Yurevych N. O., Trach O. O., Saprichova L. V., Zolotko K. M.
126-133
2020-03-03

MODERN THERAPY OF TYPE 2 DIABETES MELLITUS USING PHARMACOECONOMIC ANALYSIS

Kravchun N. A., Karachentsev Yu. I., Kozakov O. V., Romanova I. P., Cherniavskaya I. V., Karamyshev D. V., Nemchenko A. S.
5-10
2011-09-27

PANCREATIC AND EXTRA PANCREATIC EFFECTS OF GLYMEPIRIDE

Kravchun N. A.
126-132
2021-08-17

PRADER-WILLI SYNDROME: NEW OPPORTUNITIES IN TREATMENT OF ADOLESCENTS AND ADULTS

Lavryk A. S., Pylypenko V. M., Halych S. P., Zgonnyk A. Y., Dmytrenko O. P., Dabizha A. Y., Pankiv A. M.
43-50
2022-03-15

EVIDENCE BASE OF SITAGLIPTIN CLINICAL USE. 10 YEARS IN THE MARKET OF THE WORLD

Kravchun N.
74-79
2016-06-08

RELATIONSHIP BETWEEN CARBOHYDRATE EXCHANGE PARAMETERS AND INTERLEUKIN-22 IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION WITH REGARD TO CONCOMITANT TYPE 2 DIABETES MELLITUS

Zhuravleva M. I., Ryndina N. G., Dunaeva I. P.
18-22
2019-03-04

Benfotiamine new possibilities of application

Zherdeva N. N.
44-48
2021-06-24

PATIENTS USING QUESTIONNAIRES FOR EARLY DIAGNOSIS OF DIABETIC GASTROPARESIS

Kostitska I. O.
32-37
2021-08-17

UROGENITAL FORM OF DIABETIC AUTONOMOUS NEUROPATHIES: PREVALENCE, ETIOPATHOGENESIS, DIAGNOSTICS

Kravchun N. A., Tkachuk E. Yu.
80-90
2012-06-04

PRINCIPLES OF EVIDENCE MEDICINE IN COMPLEX THERAPY FOR DIABETIC POLYNEUROPATHY

Kravchun N. A.
133-138
2021-08-17

THE ANAMNESTIC INTERVIEW FOCUSING ON IMPLEMENTATION OF SOCIAL HEALTH OBESITY SURVEILLANCE AMONG CHILDREN WITHIN THE INSTITUTIONS OF HEALTH CARE (based on the results of the pilot survey)

Diachuk D. D., Yashchenko Yu. B., Zabolotna I. E.
7-15
2020-08-31

METABOLIC DISEASES AND NON-ALCOHOLIC FATTY LIVER DISEASE — FEATURES OF THE COMPOSITION OF GUT MICROBIOTA

Fadieienko G. D., Chereliuk N. I., Galchinskaya V. Y.
99-105
2020-11-12

DIAGNOSIS OF THE CARDIAC AUTONOMIC NEUROPATHY IN DIABETIC PATIENT

Shuper V. A., Shuper S. V., Rykova Ju. O., Trefanenko I. V., Shumko G. I., Reva T. V.
91-97
2019-08-28

GENETIC VARIANTS OF ADIPONECTIN AND THERAPEUTIC EFFICIENCY OF OMEGA-3 POLYUNSATURATED FATTY ACIDS IN PATIENTS TYPE 2 DIABETES MELLITUS

Gorshunska M. Yu., Karachentsev Yu. I., Kravchun N. O., Jansen E., Atramentova L. O., Gladkih O. I., Krasova N. S., Leshchenko Zh. A., Tyzhnenko T. V., Opaleiko Y. A., Pochernyaev A. K., Роltorak V. V.
5-14
2013-03-25

RATIONAL PHARMACEUTICAL THERAPY OF TYPE 2 DIABETES MELLITUS USING ENDOGEN PANCREAS RESERVES

Pilipenko V. M., Skubin V. M., Kushnaryova N. M., Korpachova-Zinych O. V.
28-34
2010-03-03

DIABETES MELLITUS AND DAILY MONITORING OF ARTERIAL PRESSURE: DIAGNOSTIC SIGNIFICANCE, PROSPECTS OF USE (literature review and own data)

Sergienko V. O., Segin V. B., Sandurska S. Yu., Ajmi S., Sergienko O. O.
91-101
2011-12-29
201 - 249 of 249 items << < 1 2 3 4 5